XERIS PHARMACEUTICALS INC Operating Expenses
XERIS PHARMACEUTICALS INC reported Operating Expenses of $31.31 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2021-08-05
- XERIS PHARMACEUTICALS INC operating expenses for the quarter ending 2021-06-30 was $31.31M, a 36.53% increase year-over-year.
- XERIS PHARMACEUTICALS INC operating expenses for the quarter ending 2021-03-31 was $23.11M, a 18.20% decline year-over-year.
- XERIS PHARMACEUTICALS INC operating expenses for the quarter ending 2020-12-31 was $23.11M, a 30.11% decline year-over-year.
- XERIS PHARMACEUTICALS INC operating expenses for the quarter ending 2020-09-30 was $20.36M, a 33.02% decline year-over-year.
- XERIS PHARMACEUTICALS INC operating expenses for fiscal 2020 was $94.65M, a 23.36% decline from fiscal 2019.
- XERIS PHARMACEUTICALS INC operating expenses for fiscal 2019 was $123.50M, a 99.94% increase from fiscal 2018.
- XERIS PHARMACEUTICALS INC operating expenses for fiscal 2018 was $61.77M, a 119.18% increase from fiscal 2017.
- XERIS PHARMACEUTICALS INC operating expenses for fiscal 2017 was $28.18M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2021-06-30 | $31.31M 10-Q · filed 2021-08-05 | $54.42M 10-Q · filed 2021-08-05 | $77.53M derived: sum of 3 quarters · filed 2021-08-05 | $97.89M derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | $23.11M 10-Q · filed 2021-05-13 | $46.22M derived: sum of 2 quarters · filed 2021-05-13 | $66.58M derived: sum of 3 quarters · filed 2021-05-13 | $89.51M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-12-31 | $23.11M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $43.47M derived: sum of 2 quarters · filed 2021-03-09 | $66.40M derived: sum of 3 quarters · filed 2021-08-05 | $94.65M 10-K · filed 2021-03-09 |
| 2020-09-30 | $20.36M 10-Q · filed 2020-11-09 | $43.29M derived: sum of 2 quarters · filed 2021-08-05 | $71.55M 10-Q · filed 2020-11-09 | $104.61M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-06-30 | $22.93M 10-Q · filed 2021-08-05 | $51.19M 10-Q · filed 2021-08-05 | $84.25M derived: sum of 3 quarters · filed 2021-08-05 | $114.64M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $28.25M 10-Q · filed 2021-05-13 | $61.31M derived: sum of 2 quarters · filed 2021-05-13 | $91.71M derived: sum of 3 quarters · filed 2021-05-13 | $126.07M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $33.06M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $63.46M derived: sum of 2 quarters · filed 2021-03-09 | $97.81M derived: sum of 3 quarters · filed 2021-03-09 | $123.50M 10-K · filed 2021-03-09 |
| 2019-09-30 | $30.39M 10-Q · filed 2020-11-09 | $64.75M derived: sum of 2 quarters · filed 2020-11-09 | $90.44M 10-Q · filed 2020-11-09 | $111.55M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $34.36M 10-Q · filed 2020-08-10 | $60.04M 10-Q · filed 2020-08-10 | $81.16M derived: sum of 3 quarters · filed 2020-08-10 | $96.68M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $25.68M 10-Q · filed 2020-05-07 | $46.80M derived: sum of 2 quarters · filed 2020-05-07 | $62.33M derived: sum of 3 quarters · filed 2020-05-07 | $75.50M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $21.11M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $36.64M derived: sum of 2 quarters · filed 2020-03-12 | $49.82M derived: sum of 3 quarters · filed 2020-03-12 | $61.77M 10-K · filed 2020-03-12 |
| 2018-09-30 | $15.53M 10-Q · filed 2019-11-07 | $28.70M derived: sum of 2 quarters · filed 2019-11-07 | $40.65M 10-Q · filed 2019-11-07 | $50.33M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $13.18M 10-Q · filed 2019-08-06 | $25.13M 10-Q · filed 2019-08-06 | $34.80M derived: sum of 3 quarters · filed 2019-08-06 | $42.55M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $11.95M 10-Q · filed 2019-05-09 | $21.63M derived: sum of 2 quarters · filed 2019-05-09 | $29.37M derived: sum of 3 quarters · filed 2019-05-09 | $35.13M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $9.68M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $17.42M derived: sum of 2 quarters · filed 2019-03-06 | $23.18M derived: sum of 3 quarters · filed 2019-03-06 | $28.18M 10-K · filed 2019-03-06 |
| 2017-09-30 | $7.74M 10-Q · filed 2018-11-08 | $13.50M derived: sum of 2 quarters · filed 2018-11-08 | $18.50M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $5.76M 10-Q · filed 2018-08-14 | $10.76M 10-Q · filed 2018-08-14 |